Wipro Ltd.

Wipro has collaborated with 4baseCare to develop precision oncology solutions that will improve the affordability and timely availability of gene testing reports for cancer patients. 4baseCare and Wipro will jointly pave the way for cancer patients to gain access to advanced genomic testing at an affordable cost and reduce the turnaround time (TAT) on test results to almost half from current market average of 30 days.

The partners will build a framework of efficient, streamlined, and well-regulated workflows for the development of advanced gene panels. Through this partnership, oncologists, cancer hospitals, and cancer clinics can tap diagnostics and prognostics cancer gene panels at an economical price point. It can help them identify and understand the genetic mutation of cancer, and design treatments to specifically target these mutations.

Wipro is a leading global information technology, consulting and business process services company.